BAL PHARMA
Back to Income Statement
|
BAL PHARMA Last 5 Year Operating Profit History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Operating Profit (Excl OI) | ₹30 Cr | ₹31 Cr | ₹25 Cr | ₹24 Cr | ₹25 Cr |
What is the latest Operating Profit of BAL PHARMA ?
| Year | Operating Profit |
|---|---|
| Mar2025 | ₹30 Cr |
| Mar2024 | ₹31 Cr |
| Mar2023 | ₹25 Cr |
| Mar2022 | ₹24 Cr |
| Mar2021 | ₹25 Cr |
How is Operating Profit of BAL PHARMA Trending?
| Years | Operating Profit | % Change | |
|---|---|---|---|
| Mar2025 | ₹30 Cr | -3.80 | |
| Mar2024 | ₹31 Cr | 22.52 | |
| Mar2023 | ₹25 Cr | 5.30 | |
| Mar2022 | ₹24 Cr | -2.70 | |
| Mar2021 | ₹25 Cr | - | |
Compare Operating Profit of peers of BAL PHARMA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| BAL PHARMA | ₹136.1 Cr | -4.1% | -5.6% | -4.9% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹450,211.0 Cr | -3% | -4.1% | 16.7% | Stock Analytics | |
| DIVIS LABORATORIES | ₹228,303.0 Cr | 0.6% | 17.5% | 41.9% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹189,233.0 Cr | 1.7% | -0.6% | 35.5% | Stock Analytics | |
| CIPLA | ₹115,672.0 Cr | -2% | -0.7% | -4.9% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹98,533.5 Cr | -1.5% | -3.5% | -2.2% | Stock Analytics | |
BAL PHARMA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| BAL PHARMA | -4.1% |
-5.6% |
-4.9% |
| SENSEX | -1.2% |
-1.2% |
-3.3% |
You may also like the below Video Courses